Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Benzbromarone Tablets

Approved

化学药品

Benzbromarone Tablets

Sano Arzneimittelfabrik GmbH🇨🇳 National Medical Products Administration

Approval Date: Aug 18, 2022
Approval ID: 8JajfhrWW65
Company: Sano Arzneimittelfabrik GmbH
Type: 化学药品

Approval Details

Approval Id: 8JajfhrWW65
Approval Number: 国药准字HJ20171301
Generic Name: 苯溴马隆片
Generic Name En: Benzbromarone Tablets
Trade Name: 立加利仙
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 50mg
Reg Date: 2022-08-18
Expired Date: 2027-08-17
Company Name: Sano Arzneimittelfabrik GmbH
Company Detail Path: /organization/sano-arzneimittelfabrik-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 18, 2022

Approval ID

8JajfhrWW65

Type

化学药品

Back to NMPA Approvals

立加利仙 - NMPA Drug Approval Details